Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SH2D4A
, comprising a single SH2 domain, is a novel protein of the SH2 signaling protein family. We have previously demonstrated
SH2D4A
is expressed ubiquitously in various tissues and is located in the cytoplasm. In this study we investigated the function of
SH2D4A
in human embryonic kidney (HEK) 293 cells using interaction analysis, cell proliferation assays, and kinase activity detection.
SH2D4A
was found to directly bind to estrogen receptor alpha (ERalpha), and prevent the recruitment of
phospholipase C
-gamma (PLC-gamma) to ERalpha. Moreover, we observed its inhibitory effects on estrogen-induced cell proliferation, involving the protein kinase C (PKC) signaling pathway. Together, these findings suggested that
SH2D4A
inhibited cell proliferation by suppression of the ERalpha/PLC-gamma/PKC signaling pathway.
SH2D4A
may be useful for the development of a new anti-cancer drug acting as an ER signaling modulator.
...
PMID:SH2D4A regulates cell proliferation via the ERalpha/PLC-gamma/PKC pathway. 1971 89